Lee Evans, MD
Urology · Hopkinsville, KYNPI 1124077508
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $39,800 of the $56,135 with a category attached, or 70.9%. Boston Scientific accounts for 92.4% of it on its own, with 32 other manufacturers making up the rest. 2025 is the largest year on record at $28,805, more than ten times the $601 reported in 2019. Among urology clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 365 payments — averaging $153.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$52K
- Coloplast$1K
- Johnson & Johnson$905
- Astellas Pharma US Inc$578
- Medtronic$314
- Procept Biorobotics Corporation$200
- plus $1K from 27 others
What the payments were for
- Consulting fees$1,5753%
- Speaking & faculty fees$39,80071%
- Travel & lodging$5,77110%
- Food & beverage$8,59715%
- Education$3921%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 168 | $51,873 |
| Coloplast | 41 | $1,003 |
| Johnson & Johnson | 47 | $905 |
| Astellas Pharma US Inc | 31 | $578 |
| Medtronic(2 entities) | 9 | $314 |
| Procept Biorobotics Corporation | 5 | $200 |
| Sumitomo Pharma America, Inc. | 7 | $130 |
| AbbVie | 6 | $126 |
| Tolmar Pharmaceuticals, Inc. | 7 | $115 |
| Pfizer | 7 | $113 |
| Axonics, Inc. | 5 | $96 |
| Innovation Technologies Inc | 1 | $73 |
| 180 Medical, Inc. | 3 | $64 |
| Urogen Pharma, Inc. | 3 | $52 |
| Ferring Pharmaceuticals Inc. | 2 | $49 |
| Urovant Sciences Inc | 3 | $44 |
| Sun Pharmaceutical Industries Inc. | 2 | $38 |
| KARL Storz Endoscopy-america | 1 | $37 |
| Tolmar, Inc. | 2 | $36 |
| Bayer | 2 | $32 |
| Valencia Technologies Corporation | 1 | $27 |
| Baxter Healthcare | 1 | $24 |
| Merck | 1 | $23 |
| Teleflex LLC | 1 | $23 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $23 |
| Olympus America Inc. | 1 | $21 |
| Blue Earth Diagnostics | 1 | $19 |
| ABC Home Medical Supply, Inc. | 1 | $19 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $18 |
| Laborie Medical Technologies Corp. | 1 | $17 |
| Endo Pharmaceuticals Inc. | 1 | $16 |
| Immunitybio, Inc. | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AdVance XP$13,776
- TACTRA$10,956
- AMS 700 CXR RTE KIT$7,068
- AMS 700$7,017
- GENERAL ERECTILE DYSFUNCTION$1,575
- GENERAL - THERAPIES$339
- AquaBeam Robotic System$111
How this compares
$56,135 in reported general payments places this provider in the 95th percentile of 139 urology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ErleadaApalutamide | 42 | $660,183 |
| MyrbetriqMirabegron | 32 | $25,491 |
| Tamsulosin Hcl | 504 | $6,836 |
| Finasteride | 445 | $5,373 |
| Potassium Citrate ErPotassium Citrate | 34 | $2,085 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 106 | $1,472 |
| Naloxone Hcl | 23 | $1,395 |
| Trimethoprim | 24 | $721 |
| Dutasteride | 35 | $699 |
| Oxybutynin Chloride | 121 | $689 |
| Oxybutynin Chloride ErOxybutynin Chloride | 13 | $567 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 59 | $533 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 147 | $525 |
| Ondansetron OdtOndansetron | 131 | $459 |
| Cefdinir | 27 | $393 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonErleada | $905 | $660,18342 claims |
| Astellas Pharma US IncMyrbetriq | $578 | $25,49132 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 139 urology providers in Kentucky.
Other urology in Hopkinsville
- Thomas SlabaughLexington$102K
- Uzoma AneleLouisville$60K
- Patrick HensleyLexington$50K
- Brooke EdwardsCrestview Hills$45K
- Robert LarkeCrestview Hills$22K
- Stephen MonnigLexington$18K
- Kellen ChoiLouisville$17K
- Rosa ParkLouisville$16K
- Brian ShayCrestview Hills$14K
- Michael DusingCrestview Hills$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.